SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-321040
Filing Date
2019-12-20
Accepted
2019-12-20 16:51:03
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d827108ds3.htm S-3 475676
2 EX-1.2 d827108dex12.htm EX-1.2 190324
3 EX-4.3 d827108dex43.htm EX-4.3 296881
4 EX-4.5 d827108dex45.htm EX-4.5 97772
5 EX-4.6 d827108dex46.htm EX-4.6 99177
6 EX-4.7 d827108dex47.htm EX-4.7 87771
7 EX-5.1 d827108dex51.htm EX-5.1 29211
8 EX-23.1 d827108dex231.htm EX-23.1 1438
9 GRAPHIC g827108g08c20.jpg GRAPHIC 36896
10 GRAPHIC g827108g1219133520501.jpg GRAPHIC 2534
  Complete submission text file 0001193125-19-321040.txt   1333744
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235655 | Film No.: 191302171
SIC: 2836 Biological Products, (No Diagnostic Substances)